1-6 of 6
Dina Brauneis, ANP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Serum Free Light Chain Response after High-Dose Melphalan and Stem Cell Transplantation Predicts Hematologic Response in AL Amyloidosis

Vanessa Fiorini Furtado, MD, Dina Brauneis, ANP, Shayna Sarosiek, MD, Karen Quillen, MDMPH, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-138500
Published: 2020
Journal Articles

Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Camille V Edwards, MD, Dina Brauneis, ANP, Karen Quillen, MDMPH, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-141560
Published: 2020
Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4578.
https://doi.org/10.1182/blood-2019-129095
Published: 2019
Journal Articles

Effect of Severe Hypoalbuminemia on Myelosuppression and Other Toxicities of High Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis Patients

Robert Meehan, MD, David Seldin, MD, John Mark Sloan, MD, Karen Quillen, MD MPH, Dina Brauneis, ANP, Anthony C Shelton, RN, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2014) 124 (21): 5906.
https://doi.org/10.1182/blood.V124.21.5906.5906
Published: 2014
Journal Articles

Long-Term Outcome Of Patients With AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience At a Single Center

Vaishali Sanchorawala, MD, Gheorghe Doros, Karen Quillen, MD, MPH, John Mark Sloan, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Kathleen T Finn, ANP, David C Seldin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3328.
https://doi.org/10.1182/blood.V122.21.3328.3328
Published: 2013
Journal Articles

Treatment of AL Amyloidosis with Two Cycles of Induction Therapy with Bortezomib and Dexamethasone Followed by Bortezomib-High Dose Melphalan Conditioning and Autologous Stem Cell Transplantation

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2019.
https://doi.org/10.1182/blood.V120.21.2019.2019
Published: 2012